Considering that activation of the ERBB2/RAS signaling pathway in prostate cancer cells may affect their growth rates, which could influence the analysis to assess their metastatic potentials, we carried out a growth curve assay using asynchronous cells. The gene discussed is ERBB2; the disease is Familial prostate cancer.